The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosis
Authors:
- Rick van MinkelenRMRick van Minkelen
- Marieke C. H. de VisserMVMarieke C. H. de Visser
- Hans L. VosHVHans L. Vos
- Rogier M. BertinaRBRogier M. Bertina
- Frits R. RosendaalFRFrits R. Rosendaal
- 15 June 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 105 (12) , 4898-4899
Abstract
FSAP is a serine protease that has 2 functions in hemostasis. It activates factor VII, thereby promoting coagulation,3 but it can also activate single-chain plasminogen activators, thus promoting fibrinolysis.4 Recently, a single nucleotide polymorphism (1601G>A) was discovered in the gene coding for FSAP, which results in the substitution of glycine 511 by glutamic acid (FSAP Marburg I) and which is present in 2% to 9% of the white population.1,5,6 The Marburg I variant has an impaired prourokinase activating potency, whereas it can still activate factor VII normally.7Keywords
This publication has 10 references indexed in Scilit:
- Marburg I polymorphism of factor VII–activating protease is associated with idiopathic venous thromboembolismBlood, 2005
- The factor VII activating protease G511E (Marburg) variant and cardiovascular riskThrombosis and Haemostasis, 2004
- Marburg I Polymorphism of Factor VII–Activating ProteaseCirculation, 2003
- The frequent Marburg I polymorphism impairs the pro-urokinase activating potency of the factor VII activating protease (FSAP)Blood Coagulation & Fibrinolysis, 2002
- Factor VII Activating Protease (FSAP): A Novel Protease in HemostasisBiological Chemistry, 2002
- A protease isolated from human plasma activating Factor VII independent of tissue factorBlood Coagulation & Fibrinolysis, 1999
- Allelic discrimination using fluorogenic probes and the 5′ nuclease assayGenetic Analysis: Biomolecular Engineering, 1999
- The FVII Activating Protease Cleaves Single-Chain Plasminogen ActivatorsPathophysiology of Haemostasis and Thrombosis, 1999
- Factor VII and Fibrinogen Levels as Risk Factors for Venous ThrombosisThrombosis and Haemostasis, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993